Abbonarsi

Epidemiologic, clinical, and microbiologic profile of infective endocarditis in Argentina: A national survey. The Endocarditis Infecciosa en la República Argentina–2 (EIRA-2) Study - 17/08/11

Doi : 10.1016/j.ahj.2005.04.008 
Ernesto Ferreiros, MD a, , Francisco Nacinovich, MD b, Jose Horacio Casabé, MD, PhD, FACC c, Juan Carlos Modenesi, MD d, Sandra Swieszkowski, MD a, Claudia Cortes, MD c, Cohen Arazi Hernan, MD a, Lucía Kazelian, MD e, Sergio Varini, MD, FACC a

on behalf of the EIRA-2 Investigatorsf

  See Appendix A for a full list of investigators and participating centers.

a Area de Investigación y Consejo de Cardiología Clínica “Dr Tiburcio Padilla,” Argentine Society of Cardiology, Buenos Aires, Argentina 
b Buenos Aires Cardiovascular Institute, Infectious Disease Department, Buenos Aires, Argentina 
c ICYCC, Cardiology Department, Favaloro Foundation, Beunos Aires, Argentina 
d Churruca Hospital, Cardiovascular Division, Buenos Aires, Argentina 
e Cosme Argerich Hospital, Cardiovascular Division, Buenos Aires, Argentina 

Reprint requests: Ernesto Ferreiros, MD, EIRA-2 Investigators, Area de Investigación y Consejo de Cardiología Clínica y Terapéutica “Dr. Tiburcio Padilla,” Sociedad Argentina de Cardiología, Azcuénaga 980 (ZIP 1115), Ciudad Autónoma de Buenos Aires, Argentina.

Riassunto

Background

This study aimed to determine the epidemiologic, clinical, microbiologic characteristics, and inhospital outcome of infective endocarditis (IE) in Argentina and compare the results with those of the 1992 IE national survey.

Methods

A prospective, multicenter study was conducted in 82 hospitals representing 16 of 24 provinces of Argentina. Patients with diagnosis of IE according to the Duke criteria were surveyed during an 18-month period.

Results

From 470 surveyed episodes of IE, 390 cases were classified as definite and 80 as possible IE. The mean age of the definite IE cases was 58.5 ± 17.3 years; male sex, 70.0%; and male-female ratio, 2.3:1. Pathological evidence of IE was available in 26.2%. There was no previously known heart disease in 35.1%, and the proportion of prosthetic valve IE was 15.9%. Causative microorganisms were streptococci, 38.3% (Streptococcus viridans 27.0%, Streptococcus bovis 5.2%, others 6.1%); enterococci, 10.2%; staphylococci, 36.7% (Staphylococcus aureus 29.8%, coagulase-negative staphylococci 6.9%); HACEK group, 6.1%; fungal, 1.4%; and polymicrobial, 2.0%. Blood culture results were negative in 10.8%. Surgical treatment was performed in 26.2%, and the overall inhospital mortality was 24.6%. Patients from the 2002 survey were older (58.5 ± 17.3 vs 51.3 ± 18.7 years, P < .01) and more frequently had underlying heart disease (64.9% vs 55.0%, P < .01): degenerative valve disease (11.5% vs 4.8%, P < .01), congenital heart disease (9.5% vs 4.2%, P < .01), and prosthetic valve IE (15.9% vs 8.5%, P < .01). Conversely, the prevalence of rheumatic valve disease was significantly less than in the 1992 survey (5.4% vs 13.0%, P < .01).

Conclusions

The EIRA-2 survey shows that the clinical profile of IE has changed in Argentina. Currently, patients with IE are older and have a higher frequency of underlying heart disease, degenerative valve disease, and prosthetic valve IE than previously. The incidence of staphylococcal IE has increased. Inhospital mortality remains high, suggesting that more aggressive measures are needed for the early identification, prevention, and treatment of IE.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2006  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 151 - N° 2

P. 545-552 - febbraio 2006 Ritorno al numero
Articolo precedente Articolo precedente
  • Asymptomatic long-term survivors of coronary artery bypass surgery enjoy a quality of life equal to the general population
  • Pamela J. Bradshaw, Konrad D. Jamrozik, Ian S. Gilfillan, Peter L. Thompson
| Articolo seguente Articolo seguente
  • Potential mechanisms between atrial dilatation and atrial fibrillation
  • Tong Liu, Guang-Ping Li

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.